Latest News about PFE
Recent news which mentions PFE
Why Pfizer's Future Looks Better in 2021
January 24, 2021
From Motley Fool
3 Reasons This Hot Stock May Not Survive 2021
January 24, 2021
From Motley Fool
3 Blockbuster Drug Launches to Watch This Year
January 24, 2021
From Motley Fool
BioNTech's Potential Winners Beyond Its COVID Vaccine
January 24, 2021
From Motley Fool
What Kind of Deals Is Pfizer Planning for the Next Few Years?
January 24, 2021
Tickers
PFE
From Motley Fool
From MarketWatch
How Are COVID Vaccine Rollouts Going in Europe?
January 23, 2021
From Motley Fool
What Does 2021 Hold for BioNTech Stock?
January 23, 2021
From Motley Fool
The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More
January 23, 2021
From Benzinga
Here Are the Biggest Hurdles for COVID Vaccinations
January 23, 2021
From Motley Fool
Could Moderna Be a Millionaire-Maker Stock?
January 23, 2021
From Motley Fool
Is This Under-the-Radar COVID Stock the Next Moderna?
January 23, 2021
From Motley Fool
Better Buy: Gilead Sciences vs. Pfizer
January 23, 2021
From Motley Fool
Top Coronavirus Vaccine Makers Will Earn Up to $23 Billion in Revenue This Year, Says New Analysis
January 22, 2021
From Motley Fool
What Investors Need to Know About Coronavirus Variants
January 22, 2021
From Motley Fool
From Motley Fool
Bill Ackman Pushes 3 Retailers to Get Directly Involved in U.S. Coronavirus Vaccine Drive
January 22, 2021
From Motley Fool
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
January 22, 2021
From Benzinga
Johnson & Johnson Could Have 100 Million COVID-19 Vaccines By April, Board Member McClellan Says
January 22, 2021
From Benzinga
3 Cheap Dividend Aristocrats to Buy Right Now
January 22, 2021
From Motley Fool
3 Warren Buffett Stocks That Should Be Surefire Winners in 2021
January 22, 2021
From Motley Fool
Pfizer, GSK-Backed ViiV First To Get FDA Approval For HIV Shots: What You Need To Know
January 22, 2021
From Benzinga
Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program
January 21, 2021
From Motley Fool
For Pfizer, the Covid-19 Vaccine ‘Honeymoon’ Is Over
January 21, 2021
From InvestorPlace
From MarketWatch
‘When older people are upset, you fix it’ — this Florida journalist has helped hundreds book COVID-19 vaccinations
January 21, 2021
From MarketWatch
7 Airline Stocks Being Fueled by Vaccine News
January 21, 2021
From InvestorPlace
Ignore the Bears and Invest in Pfizer
January 21, 2021
From InvestorPlace
Biden Stocks: 16 Stocks to Watch for a Defense Production Act Boost
January 21, 2021
From InvestorPlace
Should You Get A Vaccine If You've Already Recovered From COVID?
January 21, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.